Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001437749-25-004220
Filing Date
2025-02-18
Accepted
2025-02-18 16:30:30
Documents
1
Period of Report
2025-02-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 rdgdoc.html 4  
1 FORM 4 rdgdoc.xml 4 7386
  Complete submission text file 0001437749-25-004220.txt   8947
Mailing Address 10080 N WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014
Business Address 10080 N WOLFE ROAD SUITE SW3-200 CUPERTINO CA 95014 4085018881
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Issuer) CIK: 0001742927 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 19925 STEVENS CREEK BLVD., SUITE 100 CUPERTINO CA 95014
Business Address
Bhat Laxminarayan (Reporting) CIK: 0001818245 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38634 | Film No.: 25635474